Last reviewed · How we verify

NCT06638385: SPACE SHIELD

A Space-expanding Shield in Decompressive Hemicraniectomy for Stroke

Recruiting now NA Last updated 9 July 2025
What this trial tests

NA trial testing DCE + SPACE SHIELD in Stroke in 110 participants. Currently enrolling.

Timeline
1 June 2025
Primary endpoint
31 December 2029
30 June 2030

Quick facts

Lead sponsorInsel Gruppe AG, University Hospital Bern
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment110
Start date1 June 2025
Primary completion31 December 2029
Estimated completion30 June 2030
Sites6 locations across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Insel Gruppe AG, University Hospital Bern

Who can join

Adults 18 to 70, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Instead of the standard decompressive hemicraniectomy with subsequent cranioplasty a single surgery with the implantation of an individually molded space-expanding shield is investigated in for patients with increased intracranial pressure due to a malignant stroke.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Insel Gruppe AG, University Hospital Bern trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06638385.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing